Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
3.080
-0.170 (-5.23%)
At close: Nov 20, 2024, 4:00 PM
3.230
+0.150 (4.87%)
After-hours: Nov 20, 2024, 4:39 PM EST
Climb Bio Market Cap
Climb Bio has a market cap or net worth of $207.05 million as of November 21, 2024. Its market cap has increased by 188.42% in one year.
Market Cap
207.05M
Enterprise Value
-10.82M
1-Year Change
188.42%
Ranking
Category
Stock Price
Market Cap Chart
Since August 10, 2021, Climb Bio's market cap has decreased from $403.20M to $207.05M, a decrease of -48.65%. That is a compound annual growth rate of -18.39%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Nov 19, 2024 | 218.48M | 193.47% |
Dec 29, 2023 | 74.45M | -23.65% |
Dec 30, 2022 | 97.50M | -64.90% |
Dec 31, 2021 | 277.76M | -31.11% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Zura Bio | 209.59M |
High Tide | 209.19M |
Editas Medicine | 208.02M |
ADC Therapeutics | 206.92M |
Sera Prognostics | 205.34M |
Corbus Pharmaceuticals Holdings | 204.13M |
Personalis | 203.54M |
XBiotech | 203.32M |